These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8831100)

  • 1. Further evidence for clozapine as a dopamine D1 receptor agonist.
    Salmi P; Ahlenius S
    Eur J Pharmacol; 1996 Jun; 307(1):27-31. PubMed ID: 8831100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
    Salmi P; Ahlenius S
    Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P; Karlsson T; Ahlenius S
    Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ; Audinot V; Melon C; Newman-Tancredi A
    Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors?
    Jackson DM; Wikström H; Liao Y
    Psychopharmacology (Berl); 1998 Jul; 138(2):213-6. PubMed ID: 9718292
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs.
    Ahlenius S
    Pharmacol Toxicol; 1999 May; 84(5):193-6. PubMed ID: 10361974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
    Daly SA; Waddington JL
    Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
    Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
    Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
    Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D
    Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.